A Pilot Study of Website Information Regarding Aromatase Inhibitors: Dietary Supplement Interactions
- 1 November 2011
- journal article
- research article
- Published by SAGE Publications in The Journal of Alternative and Complementary Medicine
- Vol. 17 (11) , 1043-1049
Abstract
Objectives: Patients who have hormone receptor–positive breast cancer and who are taking aromatase inhibitors (AIs) should understand the benefits and risks of concomitant dietary supplement (DS) use. The International Society for Integrative Oncology (SIO) encourages patients to discuss DS use with their health care practitioners. The objective was to conduct a pilot study rating Internet websites from the perspective of health care practitioners for information about AI–DS interactions. Design: Five (5) Internet websites suggested by SIO were evaluated using the DISCERN instrument rating tool. The available AI–DS information on these websites was rated by 4 evaluators: 2 naturopathic doctors, 1 oncology pharmacy resident, and a pharmacy student. Results: The overall rankings ranged from 1.6 to 3.9, with considerable variability in the type of information available from the websites. The interevaluator rankings of the websites ranged from 0.44 to 0.89. The evaluators consistently found the most reliable, unbiased, and comprehensive information on AI–DS interactions at the Natural Medicines Comprehensive Database and Memorial Sloan-Kettering Cancer Center websites. However, more than one database was needed for provision of optimal patient information on AI–DS interactions. Conclusions: In order to effectively advise patients regarding AI–DS interactions, more than one website should be evaluated to assess the potential efficacy and safety of DS in women whose breast cancer is being treated with an AI.Keywords
This publication has 33 references indexed in Scilit:
- Complementary and Alternative Medicine and Supportive Care at Leading Cancer Centers: A Systematic Analysis of WebsitesThe Journal of Alternative and Complementary Medicine, 2010
- Interactions Between Herbal Medicines and Prescribed DrugsDrugs, 2009
- Getting a Grip on Aromatase Inhibitor–Associated ArthralgiasJournal of Clinical Oncology, 2008
- Use of prescription and nonprescription medications and supplements by cancer patients during chemotherapy: questionnaire validationJournal of Oncology Pharmacy Practice, 2008
- Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profilesBreast Cancer Research and Treatment, 2008
- Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic ReviewJournal of Clinical Oncology, 2008
- Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapyBreast Cancer Research and Treatment, 2007
- The use of dietary supplements in a community hospital comprehensive cancer center: implications for conventional cancer careSupportive Care in Cancer, 2005
- Efficacy of Coenzyme Q10 for Improved Tolerability of Cancer Treatments: A Systematic ReviewJournal of Clinical Oncology, 2004
- Potential of chemotherapy?herb interactions in adult cancer patientsSupportive Care in Cancer, 2004